Endovia Health Sciences, Inc. (EDVA)
$0.14-6.67%Close
SELLCRISIS · day 36
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $897,753
- Beta
- -1.15
- Short % float
- 2.71%
- Days to cover
- 1.0
- SI change
- -48.8%
- 1W
- -17.65%
- 1M
- -41.67%
- vs SPY 1W
- -17.51%
- vs SPY 1M
- -44.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-
---
[VALUATION]
P/E TTM-
P/E FWD-
SECTOR PE20.34
INDUSTRY PE30.33
P/B-
P/FCF-
EV/EBITDA-
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO-
ND/EBITDA-
BETA-1.15
Company news
FAQ
- What is LOPJLB’s current signal on EDVA?
- LOPJLB’s latest quantitative signal on Endovia Health Sciences, Inc. (EDVA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is EDVA in?
- Endovia Health Sciences, Inc. (EDVA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Endovia Health Sciences, Inc. (EDVA) do?
- Endovia Health Sciences is a diversified cannabinoid-based health sciences platform. The company's strategy focuses on three main areas: commercializing differentiated cannabinoid-based pharmaceutical products internationally, advancing cannabinoid-based human and veterinary therapeutics through U.S. regulatory pathways, and developing consumer wellness and beverage products. This marks a strat…